THE MUTAGENIC ACTIVITY OF RAZOXANE (ICRF-159) - AN ANTICANCER AGENT

被引：5
|
作者：
ALBANESE, R
WATKINS, PA
机构：
来源：
BRITISH JOURNAL OF CANCER | 1985年 / 52卷 / 05期
关键词：
D O I：
10.1038/bjc.1985.250
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：725 / 731
页数：7
相关论文
共 50 条
  • [41] RANDOMIZED TRIAL OF ORAL ADJUVANT RAZOXANE (ICRF-159) IN RESECTABLE COLORECTAL-CANCER - 5-YEAR FOLLOW-UP
    GILBERT, JM
    HELLMANN, K
    EVANS, M
    CASSELL, PG
    TAYLOR, RH
    STOODLEY, B
    ELLIS, H
    WASTELL, C
    BRITISH JOURNAL OF SURGERY, 1986, 73 (06) : 446 - 450
  • [42] PHASE I-II EVALUATION OF RAZOXANE (ICRF-159) AND DOXORUBICIN IN GASTROINTESTINAL CANCER - A SOUTHEASTERN CANCER STUDY-GROUP TRIAL
    DESIMONE, PA
    GRECO, FA
    OMURA, GA
    BARTOLUCCI, A
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1986, 9 (03): : 185 - 186
  • [43] EFFECTS OF ICRF-159 ON BURKITT-LYMPHOMA CELLS INVITRO
    WHEELER, RH
    RUDDON, RW
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1977, 18 (MAR): : 168 - 168
  • [44] EFFECTS OF ICRF-159 ON ADRIAMYCIN-INDUCED CARDIOMYOPATHY IN RATS
    DECORTI, G
    KLUGMANN, FB
    MALLARDI, F
    KLUGMANN, S
    BENUSSI, B
    GRILL, V
    BALDINI, L
    CANCER LETTERS, 1983, 19 (01) : 77 - 83
  • [45] INHIBITION OF EXPERIMENTAL COLORECTAL-CANCER BY RAZOXANE (ICRF159)
    GILBERT, JM
    THOMPSON, EM
    SLAVIN, G
    KARK, AE
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1984, 25 (MAR): : 313 - 313
  • [46] INFLUENCE OF ICRF-159 OR ICRF-186 ON CYTO-TOXICITY OF DAUNORUBICIN AND DOXORUBICIN
    SUPINO, R
    TUMORI, 1984, 70 (02) : 121 - 126
  • [47] STUDIES IN MICE TREATED WITH ICRF-159 COMBINED WITH DAUNORUBICIN OR DOXORUBICIN
    GIULIANI, F
    CASAZZA, AM
    DIMARCO, A
    SAVI, G
    CANCER TREATMENT REPORTS, 1981, 65 (3-4): : 267 - 276
  • [48] BIS-DIKETOPIPERAZINE DERIVATIVES IN CLINICAL ONCOLOGY - ICRF-159
    POSTER, DS
    PENTA, J
    MARSONI, S
    BRUNO, S
    MACDONALD, JS
    CANCER CLINICAL TRIALS, 1980, 3 (04) : 315 - 320
  • [49] INHIBITION OF CARDIOTOXIC, NEPHROTOXIC AND NEUROTOXIC EFFECTS OF DOXORUBICIN BY ICRF-159
    HU, ST
    BRANDLE, E
    ZBINDEN, G
    PHARMACOLOGY, 1983, 26 (04) : 210 - 220
  • [50] EFFECT OF ICRF-159 ON ACCUMULATION AND REPAIR OF RADIATION-DAMAGE
    TAYLOR, IW
    BLEEHEN, NM
    BRITISH JOURNAL OF CANCER, 1977, 36 (03) : 421 - 421
12345